<i>In silico</i>and<i>in vitro</i>evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimizationPiotr J. Kamola, Joel D. Parry, Sofie Eriksson et al.|Nucleic Acids Research|2015Cited by 109
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense DrugsPiotr J. Kamola, Joel D. Parry, Klio Maratou et al.|Molecular Therapy — Nucleic Acids|2017Cited by 62